Analyst Information


Joseph Catanzaro, PhD

Sr. Research Analyst

Joseph Catanzaro, PhD

 Joe Catanzaro is a vice president and senior research analyst at Piper Sandler covering biotechnology. Prior to joining Piper Sandler in 2018, Catanzaro spent four years at Cowen, where he also covered biotechnology. Before making the move to Wall Street, Catanzaro worked as a research scientist at Stony Brook University in New York. His work there focused on oncogene-mediated inflammatory signaling and resulted in multiple peer-reviewed publications. Catanzaro received his bachelor’s degree from Binghamton University in biological sciences and earned his Ph.D. in genetics from Stony Brook University.

Universe Coverage:
Healthcare:   Biotechnology
AERIAerie Pharmaceuticals, Inc.
AMAGAMAG Pharmaceuticals, Inc.
CRDFCardiff Oncology, Inc.
CPRXCatalyst Pharmaceuticals, Inc.
CLVSClovis Oncology, Inc.
CTMXCytomX Therapeutics, Inc.
GBTGlobal Blood Therapeutics, Inc.
HALOHalozyme Therapeutics, Inc.
IMGNImmunoGen, Inc.
IOVAIovance Biotherapeutics, Inc.
KROSKeros Therapeutics, Inc.
NKNantKwest, Inc.
NCNANuCana plc
OCULOcular Therapeutix, Inc.
RPTXRepare Therapeutics Inc.
SGENSeagen, Inc.